AI-generated analysis for informational purposes only. Not financial advice.
Crunching the numbers…
Crunching the numbers…
Healthcare companies, biggest first — open any for its full analysis.
| Ticker | Name | Price | P/E | Market Cap |
|---|---|---|---|---|
| LLY | Eli Lilly | $1161.05 | — | $1126.4B |
| JNJ | Johnson & Johnson | $265.53 | 30.8 | $642.8B |
| ABBV | AbbVie | $257.82 | 129.2 | $465.7B |
| UNH | UnitedHealth Group | $424.01 | 27.1 | $382.1B |
| MRK | Merck | $129.11 | — | $322.0B |
| NVO | Novo Nordisk | $51.58 | — | $226.5B |
Sign in to connect your holdings with this analysis.
Available once we have real fundamental data for NVS.
An absolute −99…+99 blend of news tone and recent price momentum, with a quarter-over-quarter delta (the change matters more than the level). This differs from the peer-relative Sentiment dimension in the score above — which ranks news tone vs comparable names — so a name can read “Bullish” here on momentum while its score Sentiment sits lower vs peers. Per-headline tags come from a finance lexicon on the headline text only (not the full article) — a fast heuristic that can misread sarcasm or a mixed headline, so treat them as a rough cue, not a judgment.